✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Our case has demonstrated 18F-FDG PET/CT is useful for showing the extent of the disease that affects treatment management in plasmacytoma.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) is successfully used for imaging malignant plasma cell disorders.
📊
Key Findings & Data:We report a case of 52-year-old male patient with high 18F-FDG uptake of pathologically proven maxillary sinus plasmacytoma that is uncommon.
💡
Conclusion & Impact:Our case has demonstrated 18F-FDG PET/CT is useful for showing the extent of the disease that affects treatment management in plasmacytoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) is successfully used for imaging malignant plasma cell disorders. Solitary plasmacytoma of head and neck is relatively rare. We report a case of 52-year-old male patient with high 18F-FDG uptake of pathologically proven maxillary sinus plasmacytoma that is uncommon. Our case has demonstrated 18F-FDG PET/CT is useful for showing the extent of the disease that affects treatment management in plasmacytoma.
🔖
Cite This Article
ÇALIŞ, M., EKMEKÇİOĞLU, Ö. (2022). 18F-FDG PET/CT Imaging of an Extramedullary Solitary Plasmacytoma of the Maxillary Sinus; A Case Report. European Archives of Medical Research, Cilt: 38 - Sayı: 1, 80–81. https://ajindex.com/articles/510297